| scholarly article | Q13442814 |
| P50 | author | Didier Raoult | Q915676 |
| Michel Drancourt | Q59314790 | ||
| P2093 | author name string | Vestris G | |
| P2860 | cites work | Effect of low intraphagolysosomal pH on antimicrobial activity of antibiotics against ingested staphylococci | Q71800112 |
| The Comparative Effectiveness of Aureomycin, Terramycin, Chloramphenicol, Erythromycin, and Thiocymetin in Suppressing Experimental Rickettsial Infections in Chick Embryos | Q78636795 | ||
| Q fever and Coxiella burnetii: a model for host-parasite interactions | Q33627622 | ||
| Commentary. Lysosomotropic agents | Q34214505 | ||
| Susceptibility of Coxiella burnetii to pefloxacin and ofloxacin in ovo and in persistently infected L929 cells | Q35330868 | ||
| Biochemical stratagem for obligate parasitism of eukaryotic cells by Coxiella burnetii | Q35368442 | ||
| In vitro evaluation of CP-62,993, erythromycin, clindamycin, and tetracycline against Chlamydia trachomatis | Q35540455 | ||
| Action of streptomycin in experimental infection with Q fever | Q36016049 | ||
| Fate of phase I and phase II Coxiella burnetii in several macrophage-like tumor cell lines | Q36424529 | ||
| Apparent recurrence of Q fever endocarditis following homograft replacement of aortic valve | Q36918969 | ||
| In vitro susceptibility of Coxiella burnetii to antibiotics, including several quinolones | Q39828392 | ||
| Antibiotic susceptibilities of two Coxiella burnetii isolates implicated in distinct clinical syndromes | Q39833040 | ||
| Q fever endocarditis in the south of France | Q40798866 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Coxiella burnetii | Q133971 |
| doxycycline | Q422442 | ||
| P304 | page(s) | 1512-1514 | |
| P577 | publication date | 1990-08-01 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Bactericidal effect of doxycycline associated with lysosomotropic agents on Coxiella burnetii in P388D1 cells | |
| P478 | volume | 34 |
| Q36491316 | Antibiotic susceptibility of Tropheryma whipplei in MRC5 cells |
| Q37291542 | Antibiotic treatment of rickettsiosis, recent advances and current concepts |
| Q36169968 | Antimicrobial therapies for Q fever |
| Q38688691 | Attenuated Leishmania induce pro-inflammatory mediators and influence leishmanicidal activity by p38 MAPK dependent phagosome maturation in Leishmania donovani co-infected macrophages |
| Q39476051 | Bacteriostatic and bactericidal activities of moxifloxacin against Coxiella burnetii |
| Q87949688 | Chloroquine and hydroxychloroquine as available weapons to fight COVID-19 |
| Q53791327 | Chronic Coxiella burnetii infection mimicking malignant hematologic disease. |
| Q36753137 | Comparison of different antibiotic regimens for therapy of 32 cases of Q fever endocarditis |
| Q40724782 | Coxiella burnetii endocarditis on a bioprosthetic valve: review of the literature apropos of a case |
| Q54218397 | Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review. |
| Q54241635 | Doxycycline desensitization in chronic Q fever-A critical tool for the clinician. |
| Q37695614 | Elevated Cholesterol in the Coxiella burnetii Intracellular Niche Is Bacteriolytic |
| Q36348726 | Emergence of q Fever. |
| Q24550691 | Endocarditis due to rare and fastidious bacteria |
| Q34991405 | Evaluation of Coxiella burnetii Antibiotic Susceptibilities by Real-Time PCR Assay |
| Q30241105 | From Q Fever to Coxiella burnetii Infection: a Paradigm Change |
| Q97535589 | Hydroxychloroquine and Covid-19: A Cellular and Molecular Biology Based Update |
| Q39865175 | In vitro activities of ceftriaxone and fusidic acid against 13 isolates of Coxiella burnetii, determined using the shell vial assay |
| Q36752586 | In vitro susceptibilities of Coxiella burnetii, Rickettsia rickettsii, and Rickettsia conorii to the fluoroquinolone sparfloxacin |
| Q35904249 | In vitro susceptibilities of spotted fever group rickettsiae and Coxiella burnetti to clarithromycin |
| Q94446906 | In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect |
| Q51742014 | Increased intracellular activity of MP1102 and NZ2114 against Staphylococcus aureus in vitro and in vivo. |
| Q36580730 | Intracellular innate resistance to bacterial pathogens. |
| Q67957336 | Intracellular microorganisms: a particular problem for chemotherapy. Introduction |
| Q81605944 | Intracellular organisms |
| Q40353595 | Long-term outcome of Q fever endocarditis: a 26-year personal survey |
| Q35374228 | Management of listeriosis. |
| Q90327245 | New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| Q33983769 | Newer macrolides as empiric treatment for acute Q fever infection |
| Q41107166 | Optimum treatment of intracellular infection |
| Q34723802 | Pefloxacin clinical pharmacokinetics |
| Q28206600 | Phagolysosomes of Coxiella burnetii-infected cell lines maintain an acidic pH during persistent infection |
| Q40593699 | Prosthetic valve endocarditis due to Coxiella burnetii: six cases |
| Q36171286 | Q Fever Presenting As Recurrent, Culture-negative Endocarditis with Aortic Prosthetic Valve Failure: A Case Report and Review of the Literature |
| Q35615074 | Q Fever: current state of knowledge and perspectives of research of a neglected zoonosis |
| Q24550722 | Q fever |
| Q56580257 | Q fever |
| Q49215687 | Q fever endocarditis after right ventricle to pulmonary artery conduit insertion: Case series and review of the literature |
| Q36533905 | Q fever endocarditis: a case report and review of the literature |
| Q37439277 | Quantitative assessment of cytosolic Salmonella in epithelial cells. |
| Q36880738 | Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century |
| Q36755802 | Shell-vial assay: evaluation of a new technique for determining antibiotic susceptibility, tested in 13 isolates of Coxiella burnetii |
| Q33876178 | Survival of Mycobacterium avium and Mycobacterium tuberculosis in acidified vacuoles of murine macrophages |
| Q40284597 | Susceptibility of Rickettsia conorii, R. rickettsii, and Coxiella burnetii to PD 127,391, PD 131,628, pefloxacin, ofloxacin, and ciprofloxacin |
| Q99711235 | The C-C Chemokine Receptor Type 4 Is an Immunomodulatory Target of Hydroxychloroquine |
| Q91620321 | The Effect of pH on Antibiotic Efficacy against Coxiella burnetii in Axenic Media |
| Q35818504 | Treatment of Q fever |
| Q41924598 | Treatment of classic Whipple's disease: from in vitro results to clinical outcome |
| Q34845436 | Tripping on acid: trans-kingdom perspectives on biological acids in immunity and pathogenesis |
Search more.